Rating
Buy
Price target
$330
Previous
$295
Implied upside
+24%

Mizuho analyst Vijay Rakesh raised the price target on Lam Research (NASDAQ: LRCX) to $330.00 (from $295.00) while maintaining an Outperform rating.

“LRCX reported a good MarQ and STRONG JunQ, guiding revenue to $6.6B (ABOVE cons. $6.05B).

Key points: 1) LRCX raised 2026E WFE to up ~27% y/y and $140B (above our ~$134B ests, Ex-1), with SAM % of WFE GROWING from mid-30% in C26E to high-30s L-T, 2) MarQ DRAM up 45% y/y, with HBM and DRAM-1c transitions driving ALD, 3) Foundry Revs up 39% y/y, with share gains and momentum in copper-plating, TSV etch and Adv.

Packaging growing >50% y/y in C26E, and 4) NAND $40B >200L conversion spend pulled-in to 2026-2027E (prior “several years”) driving potential upside.

Reiterate Outperform, Raise Estimates 6-12% Above Consensus and PT to $330 from $295, with LAM C26E topline up >30% y/y, outgrowing peers 2-3X, with FOUNDRY/DRAM share gain momentum and NAND upside.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.